1-6 of 6
Xiaohong Xu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Multicenter Phase2 Trial of Linperlisib in Relapsed or Refractory Peripheral T/NK Cell Lymphomas

Yuqin Song, Zengjun Li, Huijing Wu, Jie Jin, Hui Zhou, Keshu Zhou, Liling Zhang, Zhigang Peng, Zhiye Zhang, Hong Cen, Youchao Jia, Yuerong Shuang, Zhiming Li, Haiyan Yang, Liqun Zou, Zhifeng Li, Zhihui Zhang, Junmin Li, Junning Cao, Lugui Qiu, Shaojie Wu, Tiejun Gong, Xiaohong Xu, Zhen Wang, Jun Zhu
Journal: Blood
Blood (2023) 142 (Supplement 1): 306.
https://doi.org/10.1182/blood-2023-180137
Published: 2023
Journal Articles

A Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-Cell Lymphoma

Lugui Qiu, Jie Jin, Hong Cen, Keshu Zhou, Xiaohong Xu, Fei Li, Tao Wu, Haiyan Yang, Zhen Wang, Zhiming Li, Hanying Bao, Zusheng Xu
Journal: Blood
Blood (2022) 140 (Supplement 1): 9395–9396.
https://doi.org/10.1182/blood-2022-162127
Published: 2022
Journal Articles

A Phase Ib Study of Linperlisib in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

Jie Jin, Hong Cen, Keshu Zhou, Xiaohong Xu, Fei Li, Haiyan Yang, Zhiming Li, Hanying Bao, Zusheng Xu, Lugui Qiu, Yang Shu, Fei Li, Zhen Wang
Journal: Blood
Blood (2021) 138 (Supplement 1): 1386.
https://doi.org/10.1182/blood-2021-150215
Published: 2021
Journal Articles

Preliminary Results from a Phase I Study of SHC014748M in Patients with Relapsed or Refractory Indolent B-Cell Lymphomas

Wei Xu, MD PhD, Jie Jin, MD PhD, Keshu Zhou, MD, Li Wang, MD, Huayuan Zhu, Jiejing Qian, Jianying Huang, Fuling Zhou, MD, Xiaohong Xu, Zhiqiang Wang, Wei Guo, Jianyong Li, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4000.
https://doi.org/10.1182/blood-2019-126707
Published: 2019
Journal Articles

Apolipoprotein Α-IV Is a Novel Ligand of Platelet αIIbβ3 Integrin and an Endogenous Thrombosis Inhibitor: Measurement of Single-Molecular Interactions By Biomembrane Force Probe

Xiaohong Xu, MD, Christopher M. Spring, MSc, Lining Ju, PhD, Yiming Wang, MD, Adili Reheman, MD, Hong Yang, MD, Joseph Wuxun Jin, PhD, Xi Lei, MSc, Yan Yang, MD PhD, Emily C. Reddy, PhD, Yunfeng Chen, PhD, Pingguo Chen, MD PhD, Guangheng Zhu, MD, Patrizia Marchese, PhD, Alessandro Zarpellon, PhD, Hailong Zhang, PhD, YiMin She, PhD, Terry Cyr, PhD, Cheng Zhu, PhD, John Freedman, MD, Patrick Tso, PhD, Sean Davidson, PhD, Zaverio M. Ruggeri, MD, Heyu Ni, MD PhD
Journal: Blood
Blood (2014) 124 (21): 92.
https://doi.org/10.1182/blood.V124.21.92.92
Published: 2014
Journal Articles

Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature

Chad May, Jacqueline F. Doody, Rashed Abdullah, Paul Balderes, Xiaohong Xu, Chien Peter Chen, Zhenping Zhu, Lawrence Shapiro, Paul Kussie, Daniel J. Hicklin, Fang Liao, Peter Bohlen
Journal: Blood
Blood (2005) 105 (11): 4337–4344.
https://doi.org/10.1182/blood-2005-01-0010
Published: 2005